Owiglit-PG2 Tablet
Marketer
Solwin Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Owiglit-PG2 Tablet
GlycoBalance-DX tablets combine medications to manage blood glucose. This treatment, used alongside diet and exercise, enhances blood sugar control in adults with type 2 diabetes. It improves insulin efficiency, reducing blood sugar. Follow your doctor's prescribed dosage and duration; take with food to prevent stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double the dose; overdose risks dangerously low blood sugar (hypoglycemia). Hypoglycemia can occur with concurrent antidiabetic medications, alcohol, or missed meals. Regular blood sugar monitoring is essential. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fracture, and respiratory infections. Prior to use, disclose kidney, liver, or heart conditions to your physician. Pregnant or lactating individuals require medical consultation before use. Kidney function tests are typically performed before treatment begins. Limit alcohol consumption as it can increase adverse effects.
Uses of Owiglit-PG2 Tablet
Managing type 2 diabetes
Major Benefits of Owiglit-PG2 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Owiglit-PG2 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Owiglit-PG2 Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Owiglit-PG2 Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Owiglit-PG2 Tablets should be administered with food.
How Owiglit-PG2 Tablet works:
Owiglit-PG2 Tablet combines three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. This triple-action approach offers superior blood glucose management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this by further improving insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Owiglit-PG2 Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Owiglit-PG2 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Maternal use of Owiglit-PG2 tablets while breastfeeding is potentially unsafe. Available human data indicates possible drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should use Owiglit-PG2 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Owiglit-PG2 Tablet use. Physician consultation is essential. Routine kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Owiglit-PG2 Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Owiglit-PG2 Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Owiglit-PG2 Tablet :
Should you forget a dose of Owiglit-PG2 Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Owiglit-PG2 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |

